MAP
GILD icon

Moody Aldrich Partners’s Gilead Sciences GILD Stock Holding History

Moody Aldrich Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,858
Closed -$429K – 212
2024
Q1 		$429K Hold
5,858
– – 0.07% 151
2023
Q4 		$475K Hold
5,858
– – 0.09% 135
2023
Q3 		$439K Buy
+5,858
New +$451K 0.08% 133

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Moody Aldrich Partners's GILD Position: Q2 2024 in Review

Moody Aldrich Partners sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 5,858 shares — an estimated $429K sold.

Moody Aldrich Partners first reported a position in GILD in Q3 2023 and held it in 3 quarters. The position peaked at $475K in Q4 2023. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Moody Aldrich Partners reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 5,858 Gilead Sciences shares in Q2 2024, an estimated $429K.
  • Moody Aldrich Partners first reported a position in Gilead Sciences in Q3 2023 and held it in 3 quarters.
  • Moody Aldrich Partners's Gilead Sciences position peaked at $475K in Q4 2023.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.